Greater Cannabis (GCAN) Competitors $0.0004 0.00 (-20.00%) (As of 12/20/2024 12:13 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends GCAN vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDWShould you be buying Greater Cannabis stock or one of its competitors? The main competitors of Greater Cannabis include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry. Greater Cannabis vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera biote 180 Life Sciences (NASDAQ:ATNFW) and Greater Cannabis (NASDAQ:GCAN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, community ranking, dividends and institutional ownership. Which has higher valuation & earnings, ATNFW or GCAN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AGreater CannabisN/AN/AN/AN/AN/A Does the media prefer ATNFW or GCAN? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Greater Cannabis'average media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Greater Cannabis Neutral Is ATNFW or GCAN more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Greater Cannabis N/A N/A N/A Does the MarketBeat Community prefer ATNFW or GCAN? Greater Cannabis received 10 more outperform votes than 180 Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AGreater CannabisOutperform Votes1076.92% Underperform Votes323.08% SummaryGreater Cannabis beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Ad InvestorPlaceWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.This market shakeup is going to be much more intense. Get Greater Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for GCAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GCAN vs. The Competition Export to ExcelMetricGreater CannabisDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$1.17B$5.14B$9.08BDividend YieldN/A3.04%5.09%4.23%P/E RatioN/A131.2390.0517.16Price / SalesN/A1,981.001,117.09117.04Price / CashN/A10.2543.1037.86Price / BookN/A3.084.784.78Net IncomeN/A$152.21M$120.31M$225.60M7 Day PerformanceN/A-0.48%-1.92%-1.23%1 Month PerformanceN/A-1.88%13.65%0.46%1 Year PerformanceN/A98.32%28.34%15.24% Greater Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GCANGreater CannabisN/A$0.00-20.0%N/A-50.0%$0.00N/A0.001Gap DownATNFW180 Life SciencesN/A$0.01+1.2%N/A+31.6%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/A$0.04-25.7%N/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.16+6.2%N/A+22.1%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.03-42.9%N/A-89.6%$0.00$40,633.000.0040News CoveragePositive NewsALVOWAlvotechN/A$2.78+1.1%N/A+48.5%$0.00$391.87M0.004ALVOAlvotech2.6568 of 5 stars$12.13+2.8%$18.00+48.4%+6.9%$0.00$93.38M0.001,026ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.06+50.0%N/A+408.0%$0.00N/A0.004High Trading VolumeACABUAtlantic Coastal Acquisition Corp. IIN/A$8.05-26.8%N/AN/A$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.09-0.1%N/A+340.0%$0.00$35.36M0.0070Positive NewsBTMDWbioteN/A$1.61+15.8%N/A-56.1%$0.00$193.06M0.00N/A Related Companies and Tools Related Companies ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ALVO Alternatives ACABW Alternatives ACABU Alternatives BFRIW Alternatives BTMDW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GCAN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Greater Cannabis Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greater Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GCAN Stock Alerts